Off-Label Use of Intravenous Immunoglobulin for Hematological Conditions: Clinical Effectiveness


( Last Updated : October 24, 2017)
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1150-000

Details


Question


  1. What is the clinical effectiveness of the off-label use of intravenous or subcutaneous immunoglobulin for the treatment of hematological conditions?


Key Message

Three systematic reviews (one with meta-analyses), four randomized controlled trials, and four non-randomized studies were identified regarding the clinical effectiveness of the off-label use of intravenous or subcutaneous immunoglobulin for the treatment of hematological conditions.